The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correction to Connolly et al., N Engl J Med 337(9):581-588 August 28, 1997.

Correction
PreviousPrevious
Volume 337:1783 December 11, 1997 Number 24

Valvular Heart Disease Associated with Fenfluramine–Phentermine

 

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
by Connolly, H. M.
Valvular Heart Disease Associated with Fenfluramine–Phentermine . On page 587, the sentence that begins in line 10 of the right-hand column should have read, "Commonly used doses of these medications are 20 to 120 mg of fenfluramine per day and 18.75 to 37.5 mg of phentermine hydrochloride per day or 15 to 30 mg of phentermine resin per day," not "18.75 to 37.5 mg of phentermine resin . . . or . . . 15 to 30 mg of phentermine hydrochloride," as printed.



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.